336 related articles for article (PubMed ID: 25874965)
1. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.
Patel VB; Takawale A; Ramprasath T; Das SK; Basu R; Grant MB; Hall DA; Kassiri Z; Oudit GY
J Mol Med (Berl); 2015 Sep; 93(9):1003-13. PubMed ID: 25874965
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
3. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells.
Zhang Y; Wang SJ; Han ZH; Li YQ; Xue JH; Gao DF; Wu XS; Wang CX
Int J Clin Exp Pathol; 2014; 7(11):8112-7. PubMed ID: 25550859
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways.
Xiao X; Zhang C; Ma X; Miao H; Wang J; Liu L; Chen S; Zeng R; Chen Y; Bihl JC
Exp Cell Res; 2015 Aug; 336(1):58-65. PubMed ID: 26101159
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.
Chen LJ; Xu YL; Song B; Yu HM; Oudit GY; Xu R; Zhang ZZ; Jin HY; Chang Q; Zhu DL; Zhong JC
Peptides; 2016 May; 79():49-57. PubMed ID: 27018342
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
[TBL] [Abstract][Full Text] [Related]
8. Baicalin attenuates angiotensin II-induced endothelial dysfunction.
Wei X; Zhu X; Hu N; Zhang X; Sun T; Xu J; Bian X
Biochem Biophys Res Commun; 2015 Sep; 465(1):101-7. PubMed ID: 26239661
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
Shi Y; Lo CS; Padda R; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Clin Sci (Lond); 2015 May; 128(10):649-63. PubMed ID: 25495544
[TBL] [Abstract][Full Text] [Related]
10. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
[TBL] [Abstract][Full Text] [Related]
12. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
13. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F
Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385
[TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
15. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
[TBL] [Abstract][Full Text] [Related]
16. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats.
Lo J; Patel VB; Wang Z; Levasseur J; Kaufman S; Penninger JM; Oudit GY
Exp Physiol; 2013 Jan; 98(1):109-22. PubMed ID: 22750422
[TBL] [Abstract][Full Text] [Related]
18. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity.
Polak Y; Speth RC
Peptides; 2021 Mar; 137():170477. PubMed ID: 33400951
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Yousif MH; Dhaunsi GS; Makki BM; Qabazard BA; Akhtar S; Benter IF
Pharmacol Res; 2012 Sep; 66(3):269-75. PubMed ID: 22580236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
